Airway Administration Of Angiogenesis Inhibitors

The text shown here has been derived from the original document's published images via a process of ´optical character recognition (OCR). Due to variations in image quality, and the imperfect nature of OCR process, this text may not be 100% accurate. To view the original published images, please refer to the PDF.


(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT)

(19) World Intellectual Property Organization International Bureau (43) International Publication Date 1 5 March 2012 (15.03.2012)

(10) International Publication Number

PO

PCT

WO 2012/031603 A 3
CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.

(51) International Patent Classification: A61K 9/72 (2006.01) A61P 35/00 (2006.01) A61K 31/454 (2006.01) A61P 11/00 (2006.01) (21) International Application Number:
PCT/DK201 1/050338

(22) International Filing Date:
>September 201 1 (09.09.201 1)

(84) Designated States (unless otherwise indicated, for every kind o regional protection available): ARIPO (BW, GH, f English (26) Publication Language: GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, (30) Priority Data: TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, PA 2010 00807 9 September 2010 (09.09.2010) DK EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, (71) Applicant (for all designated States except US) : TRIFOLMC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, LIUM APS [DK/DK]; Kongevejen 153, DK-2830 Virum TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, (DK). ML, MR, NE, SN, TD, TG).
(25) Filing Language:
English

(72) Inventors; and (75) Inventors/ Applicants (for US only): HESLET, Lars [DK/DK]; Parkovsvej 20, DK-2820 Gentofte (DK). FIALA, Kaare [DK/DK]; Egernvej 69, DK-2000 Frederiksberg (DK). (74) Agent: H0IBERG A/S; St. Kongensgade 59 A , DK-1264 Copenhagen K (DK). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ,

Published:

— —

with international search report (Art. 21(3))

before the expiration of the time limit for amending the claims and to be republished in the event of receipt o f amendments (Rule 48.2(h))
with sequence listing part of description (Rule 5.2(a))

—

(88) Date of publication of the international search report: 16 August 2012

<
o © o
(54) Title: AIRWAY ADMINISTRATION O F ANGIOGENESIS INHIBITORS (57) Abstract: The present invention provides methods for the local pulmonary treatment of lung metastases and/or primary lung cancer, such a s squamous lung cancer and/or small cell lung cancer, using local deposition of one or more agents capable of inhib it ing angiogenesis and/or an agent that acts a s an active anti-cancer agent and/or an active anti-metastatic agent. The agent capable of inhibiting angiogenesis and/or which acts a s an active anti-cancer agent and/or an active anti-metastatic agent i s administered to a patient with cancer a s a treatment of said metastasis and/or cancer or t o extend the lifespan for said cancer patient with reduced sys temic side- effects compared t o other treatment forms. The agent capable of inhibiting angiogenesis and/or which acts a s an active anti-cancer agent and/or an active anti- metastatic agent i s administered intratracheal, intrabronchial, intraalveolar or broncioalveol ar. Administration for example via inhalation of an aerosol or a s a dry powder and/or administered a s a bronchoalveolar lavage (BAL) an effective amount of the agent.

o

A . CLASSIFICATION

O F SUBJECT

MATTER

INV.
ADD.

A61K9/72

A61K31/454

A61P35/00

A61P11/00

A61K9/00

According t o International B . FIELDS SEARCHED Minimum documentation

Patent Classification

(IPC) o r t o both national classification

and IPC

searched

(classification

system followed b y classification

symbols)

A61K

A61P

Documentation

searched other than minimum documentation

t o the extent that such documents

are included

in the fields searched

Electronic data base consulted during the international

search (name o f data base and, where practicable,

search terms used)

EPO-Internal

, BIOSIS,

EMBASE, WPI Data

C . DOCUMENTS Category*

CONSIDERED

T O B E RELEVANT where appropriate, o f the relevant passages Relevant t o claim No.

Citation o f document, with indication,

WO

2005/046593 A2 (CELGENE CORP [US] ; ZELDIS JEROME B [US] ) 2 6 May 2005 (2005-05-26) pages 1 , 3 , 10 2009/108932 A2 (UNIV JOHNS HOPKINS) 3 September 2009 (2009-09-03) pages 3 , 5 ,51 ; c l aims 2009/080830 Al (BI0TEST
AG

1-11 , 18-29

W0

1-8, 14, 15 , 18-29

W0

[DE] ;

IMMUN0GEN INC [US] ; KRAUS ELMAR [DE] ; BRUECHER CHRIST) 2 July 2009 (2009-07-02)

1-8, 14, 15 , 18-29

pages 5 ,28,38;
W0

c l aims 1-8, 12 , 13 , 18-29

03/014315 A2 (CHI LDRENS MEDICAL CENTER [US] ; ENTREMED INC [US] ) 2 0 February 2003 (2003-02-20) pages 1 ,28

-/-X|
Further documents are listed i n the continuation : "T" later document published after the international filing date o r priority date and not i n conflict with the application but cited t o understand the principle o r theory underlying the invention "X" document o f particular relevance; the claimed invention cannot b e considered novel o r cannot b e considered t o involve a n inventive step when the document is taken alone "Y" document o f particular relevance; the claimed invention cannot b e considered t o involve a n inventive step when the document is combined with one o r more other such documents, such combination being obvious t o a person skilled i n the art "&" document search member o f the same patent family search report o f Box C .

XI

See patent family annex.

* Special categories

o f cited documents

"A" document defining the general state o f the art which is not considered t o b e o f particular relevance "E" earlier application filing date o r patent but published o n o r after the international

"L" documentwhich may throw doubts o n priority claim(s) orwhich is cited t o establish the publication date o f another citation o r other special reason (as specified) "O" document means referring t o a n oral disclosure, use, exhibition o r other filing date but later than

"P" document published prior t o the international the priority date claimed Date o f the actual completion o f the international

Date o f mailing o f the international

19 June 2012
Name and mailing address o f the ISA/ European Patent Office, P.B. 5818 Patentlaan 2 N L - 2280 H V Rijswijk Tel. (+31-70) 340-2040, Fax: (+31-70) 340-3016

03/07/2012
Authorized officer

Hel l er,

Dorothee

C(Continuation).
Category*

DOCUMENTS CONSIDERED TO B E RELEVANT
Relevant to claim No.

Citation of document, with indication, where appropriate, of the relevant passages

WO

2007/127488 A l (SHENOY NARMADA R [US] ) 8 November 2007 (2007-11-08) pages 1 ,42 ,52 ; exampl e V
CARMELI ET P ET AL: "ANGI0GENESIS I N CANCER AND OTHER DISEASES" , NATURE: INTERNATIONAL WEEKLY JOURNAL O F SCI ENCE, NATURE PUBLISHING GROUP, UNITED KINGDOM,

1-29

1-29

vol . 407 , no. 6801 , 14 September 2000 (2000-09-14) , pages 249-257 , XP000918984, ISSN : 0028-0836, D0I : 10. 1038/35025220 abstract; tabl e s
SANDLER ALAN ET AL:

1-29

" Pacl i taxel -carbopl ati n a l one o r wi t h bevaci zumab for non-smal 1 -eel 1 l ung cancer" , NEW ENGLAND JOURNAL O F MEDICINE, THE, MASSACHUSETTS MEDICAL SOCI ETY, WALTHAM, MA, US, vol . 355 , no. 24, 14 December 2006 (2006-12-14) , pages 2542-2550, XP002593420, ISSN : 0028-4793 abstract

Patent document cited in search report

Publication date

Patent family member(s)

Publication date

W O 2005046593

A2

26-05-2005

AU BR CA CN EA EP EP P KR OA US WO ZA
US WO

2004288714 PI0416275 2545128 1901911 200600921 1684758 2077112 2007510670 20060124607 13284 2007208057 2005046593 200603718

Al

A
Al

A
Al A2 Al

A A A
Al A2

A

26-05-2005 23-01-2007 26-05-2005 24-01-2007 27-10-2006 02-08-2006 08-07-2009 26-04-2007 05-12-2006 31-01-2007 06-09-2007 26-05-2005 26-09-2007 06-01-2011 03-09-2009 03-03-2010 02-07-2009 02-07-2009 02-02-2011 27-10-2010 10-03-2011 03-09-2010 01-08-2009 17-09-2009 02-07-2009
15-05-2009 20-02-2003 15-06-2009 02-06-2004 24-09-2009 30-06-2010 24-12-2004 25-11-2005 21-07-2009 24-07-2003 10-05-2007 20-02-2003 26-04-2006

W O 2009108932

A2

03-09-2009

2011003710 A l 2009108932 A 2 069980 2008339911 2710471 101965366 2242772 2011507932 20100097753 200932272 2009232810 2009080830
428419 2457319 1423115 1423115 2325916 4494013 2004538322 531294 1423115 2003139451 2007105903 03014315 200400924
Al Al Al

W 0 2009080830

Al

02-07-2009

AR
AU CA CN EP P KR TW US WO

A
Al

A A A
Al Al

W 0 03014315

A2

20-02-2003

AT CA DK
EP ES

T
Al T3 A2 T3 B2

P JP NZ
PT US US WO ZA

A A E
Al Al A2

A
Al

W 0 2007127488

Al

08-11-2007

EP

JP US WO

2019649 2010500050 2010021519 2007127488

A
Al Al

04-02-2009 07-01-2010 28-01-2010 08-11-2007



Download Citation


Sign in to the Lens

Feedback